Intercell Acquires Monoclonal Antibody Assets from Cytos
By Debbie Tranter
Pharma Deals Review: Vol 2010 Issue 5 (Table of Contents)
Published: 3 Jun-2010
DOI: 10.3833/pdr.v2010.i5.1344 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Cytos is to transfer its monoclonal antibody (mAb) technology platform, a specific application of the so-called DELphi™ technology, to Intercell for EUR 15 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS